Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1390777 NEW YORK, NY
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,424,362
+$1,209,811 QoQ
Shares Held
218,126
+171.4% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 111 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ACHV ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in ACHV

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,424,362 218,126
2025-03-31 $214,551 80,357
2024-12-31 $273,755 77,772
2024-09-30 $366,007 77,217
2024-06-30 $482,007 102,555
2023-12-31 $47,136 11,441
2023-09-30 $49,196 11,441
2023-06-30 $59,378 11,441
2023-03-31 $79,368 11,672